Ben Liu is the co-founder and CEO of Formation Bio. He received his DPhil at Oxford as a Rhodes Scholar, leveraging machine-learning, AI, and big-data to develop diagnostics and therapeutics for Parkinson’s and Alzheimer’s disease. During his graduate work, he observed the way clinical trials bottlenecked the development of new treatments for patients, compelling him to start Formation Bio. Before Formation Bio, Ben graduated from Yale where he was awarded the college’s highest honor at graduation. Ben also serves as an Advisor to Harvard Business School’s MS/MBA Program in Biotechnology.